Manuscripts
Showing 45 manuscripts.
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.
Citation
Jennifer A. Hughes, Mauricio Pinilla, Kristina M. Brooks, Ahizechukwu C. Eke, Alice Stek, Brookie M. Best, Mark Mirochnick, Renee Browning, Lubbe Wiesner, Kathleen George, Kevin Knowles, Petra De Koker, Nahida Chakhtoura, Anneke C. Hesseling, Eric Decloedt, David E. Shapiro, Marije van Schalkwyk, IMPAACT P1026s Protocol Team. Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.. Clinical Pharmacology. 2025. 64: 619-630. PMID: 40155501Year
2025
Journal
Clinical Pharmacology
Study
P1026S
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s
Citation
Tim R. Cressey, David E. Shapiro, Kira Bacon, Kevin Knowles, Kathleen George, Renee Browning, Nahida Chakhtoura, Kittipong Rungruengthanakit, Lubbe Wiesner, Marije Van Schalkwyk, Edmund V. Capparelli, Adrie Bekker, Alice M. Stek, Eric Decloedt, Mark Mirochnick, Jiajia Wang, Brookie M. Best, Gerhard B. Theron, IMPAACT P1026s Protocol Team, Mark F. Cotton, Ahizechukwu C. Eke. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s. Journal Antimicrobial Agents and Chemotherapy. 2023. 67: e0073723. PMID: 37882552Year
2023
Journal
Journal Antimicrobial Agents and Chemotherapy
Study
P1026S
Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum
Citation
Jeremiah D. Momper, Mina Nikanjam, Brookie M. Best, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey. Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum. Journal of Acquired Immune Deficiency Syndromes. 2023. 94: 332-336. PMID: 37884053Year
2023
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s
Citation
Alice M. Stek, David E. Shapiro, Emily Barr, Irma L. Febo, Mary E. Paul, Jaime G. Deville, Kathleen George, Kevin Knowles, Kittipong Rungruengthanakit, Renee Browning, Nahida Chakhtoura, Edmund V. Capparelli, Mark Mirochnick, Brookie M. Best, Kristina M. Brooks, IMPAACT P1026s Protocol Team, Mauricio Pinilla. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. Journal of Acquired Immune Deficiency Syndromes. 2022. 90: 343-350. PMID: 35195573Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens
Citation
Brookie M Best, Edmund Capparelli, Jiajia Wang, David Shapiro, Nahida Chakhtoura, Mark Mirochnick, Ahizechukwu C Eke, Regis Kreitchmann, Alice Stek, IMPAACT P1026s protocol team. Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens. Contraception. 2022. 105: 67-74. PMID: 34407424Year
2022
Journal
Contraception
Study
P1026S
Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV
Citation
David E Shapiro, Kathleen M Powis, Mary E Paul, Martina L Badell, Renee Browning, Nahida Chakhtoura, Kayla Denson, Kittipong Rungruengthanakit, Kathleen George, Edmund V Capparelli, Mark Mirochnick, Brookie M Best, Jeremiah D Momper, IMPAACT P1026s Protocol Team, Alice Stek, Kathleen Powis, Jiajia Wang. Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV. Journal of Acquired Immune Deficiency Syndromes. 2022. 89: 303-309. PMID: 34732682Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Optimizing Dolutegravir Initiation in Neonates using Population Pharmacokinetic Modeling and Simulation
Citation
Brookie M. Best, Edward Acosta, Mark Mirochnick, Diana F. Clarke, Edmund V. Capparelli, Jeremiah D. Momper, Joseph Piscitelli, Mina Nikanjam. Optimizing Dolutegravir Initiation in Neonates using Population Pharmacokinetic Modeling and Simulation. Journal of Acquired Immune Deficiency Syndromes. 2022. 89: 108-114. PMID: 34629412Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV
Citation
Rowena Espina, Mauricio Pinilla, Edmund V Capparelli, Alice M Stek, Mark Mirochnick, Emily Barr, Brookie M Best, Adriana Weinberg, IMPAACT P1026s Protocol Team, Jaime G Deville, Irma L Febo, Mikhaela Cielo, Kathleen George, Kayla Denson, Kittipong Rungruengthanakit, David E Shapiro, Elizabeth Smith, Nahida Chakhtoura, James F Rooney, Kristina M Brooks, Richard Haubrich, Jeremiah D Momper. Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. AIDS. 2021. 35: 407-417. PMID: 33252495Year
2021
Journal
AIDS
Study
P1026S
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV
Citation
David E Shapiro, Gwendolyn B Scott, Mary E Paul, Irma L Febo, Derek Z Yang, Edmund V Capparelli, Jeremiah D Momper, Brookie M Best, Alice Stek, Sandra Burchett, Elizabeth Smith, Nahida Chakhtoura, Kayla Denson, Kittipong Rungruengthanakit, Kathleen George, Mark Mirochnick, Jiajia Wang, IMPAACT P1026s Protocol Team. Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV. AIDS. 2021. 35: 1191-1199. PMID: 34076612Year
2021
Journal
AIDS
Study
P1026S
Lopinavir and tenofovir interaction observed in non-pregnant adults altered during pregnancy
Citation
Jeremiah D Momper, Edmund V Capparelli, Alice Stek, Nahida Chakhtoura, Mark Mirochnick, Brookie M Best, IMPAACT P1026s Protocol Team, Nikki Mulligan, Engie Salama. Lopinavir and tenofovir interaction observed in non-pregnant adults altered during pregnancy. Journal of Clinical Pharmacy and Theraputics. 2021. 46: 1459-1464. PMID: 34254323Year
2021
Journal
Journal of Clinical Pharmacy and Theraputics
Study
P1026S